Last $0.25 USD
Change Today -0.0007 / -0.28%
Volume 1.4M
HEB On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 3:59 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

William A. Carter M.D.

Chairman, Chief Executive Officer, President, Chief Scientific Officer, Chairman of Executive Committee, Member of Strategic Planning Committee and Member of Disclosure Controls Committee, Hemispherx Biopharma, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 board members in 1 different organizations across 1 different industries.

See Board Relationships
76$1,465,960
As of Fiscal Year 2013

Background*

Dr. William A. Carter, M.D. has been the Chairman, Chief Executive Officer, President and Chief Scientific Officer of Hemispherx Biopharma Inc. since January 1992, July 1993, December 2011 and May 1989 respectively. Dr. Carter joined Hemispherx Biopharma Inc., in 1978 and served as its Chairman from 1987 to 1988 and President from April 1995 to November 2006. Dr. Carter is co-inventor of Ampligen. Dr. Carter received the first FDA approval to initiate clinical trials ...

Read Full Background

Corporate Headquarters*

One Penn Center
Philadelphia, Pennsylvania 19103

United States

Phone: 215-988-0080
Fax: 215-988-1739

Board Members Memberships*

1987-Present
Chairman, Chief Executive Officer, President, Chief Scientific Officer, Chairman of Executive Committee, Member of Strategic Planning Committee and Member of Disclosure Controls Committee

Education*

MD
Duke University
Post-Doctoral Training
Johns Hopkins University

Other Affiliations*

Annual Compensation*

Salary$1,000,389
Bonus$12,444
Total Annual Compensation$1,012,833

Stock Options*

All Other Compensation$147,662
Exercisable Options7,365,378
Unexercisable Options650,000
Unexercisable Options Value$3,000
Total Value of Options$3,000
Total Number of Options8,015,378

Total Compensation*

Total Annual Cash Compensation$1,340,261
Total Short Term Compensation$1,012,833
Other Long Term Compensation$147,662
Total Calculated Compensation$1,465,960
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HEB:US $0.25 USD -0.0007

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Frank Mathias Chief Executive Officer and Member of Executive Board
MediGene AG
€563.0K
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
--
Robert L. Parkinson Jr.Chairman, Chief Executive Officer and President
Baxter International Inc.
$1.5M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.0M GBP
Christopher Nishan Garabedian Chief Executive Officer, President and Director
Sarepta Therapeutics, Inc.
$580.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HEMISPHERX BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.